Biovie Inc (BIVI) Live Share Price, Invest From India

Biovie Inc Stock Performance

as on March 17, 2026 at 6:59 am IST

Day's Low
Day's High
$1.38
Day's Price Range
$1.46
$1.45
4.83%
Downside
0.69%
Upside
52 Week's Low
52 Week's High
$1.06
52-Week Price Range
$13.20
$1.45
26.90%
Downside
810.34%
Upside

Biovie Inc share price movements today

Previous Close: $1.41
Open: $1.41
Volume: 308.5K
Day's Low - High: $1.38 - $1.46
52 Week Low - High: $1.06 - $13.20

Biovie Inc Historical Returns

1 Month Return: + 11.02 %
3 Month Return: -1.4 %
1 Year Return: -86.94 %
3 Year Return: -99.87 %
5 Year Return: -99.93 %

Biovie Inc Stock Fundamentals & Key Indicators

Check Biovie Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$11.2M

EPS (TTM)

-3.02

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-19.0M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-94.79%

Biovie Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Biovie Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Biovie Inc	SELL	$11.2M	-99.93%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$41.6B	117.98%	135.09	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$119.2B	114.32%	30.68	32.94%
Beone Medicines Ltd	NA	$32.8B	NA	115	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$78.8B	54.67%	17.99	31.41%

Stock Returns calculator for Biovie Inc Stock including INR - Dollar returns

The Biovie Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Biovie Inc investment value today

Current value as on today

₹19,925

Returns

₹80,075

(-80.07%)

Returns from Biovie Inc Stock

₹86,574 (-86.57%)

Dollar Returns*

₹6,499 (+6.5%)

Analyst Recommendation on Biovie Inc Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Biovie Inc. Average target price of $12

Biovie Inc Share Price Target

Get share price movements and forecasts by analysts on Biovie Inc.

What analysts predicted

87.92%UPSIDE

Target Price

$12

Current Price

$1.45

Analyzed by

6 Analysts

Target

$12.00

Biovie Inc target price $12, a slight upside of 87.92% compared to current price of $1.45. According to 6 analysts rating.

Biovie Inc Stock’s Investor Sentiment and Interest

Search interest for Biovie Inc Stock has increased by 221% in the last 30 days, reflecting an upward trend in search activity.

Time period: February 15, 2026 to March 17, 2026

Change:221% versus previous 30 day period

Biovie Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-10	-8	-7	-4	-4	-7	-2	-3	-5	-6
EBITDA	-9	-8	-7	-4	-4	-7	-2	-3	-5	-6
Interest Expense	1	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-10	-8	-8	-4	-4	-7	-2	-3	-5	-6
Income Tax Expense	1	0	0	0	-4	-7	-	7	-	-
Net Income	-10	-8	-8	-4	-4	-7	-2	-3	-5	-6
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Biovie Inc Annual Profit & Loss

All numbers in Millions USD

	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	0	-1	-2	-2	-2	-138	-27	-45	-32	-18
EBITDA	0	-1	-2	-2	-2	-137	-27	-45	-31	-16
Interest Expense	0	0	0	0	4	0	2	4	2	0
Depreciation	-	0	0	0	0	0	0	0	0	0
Income Before Tax	0	-1	-2	-2	-16	-130	-26	-50	-32	-17
Income Tax Expense	0	0	0	0	4	0	-3	4	0	-
Net Income	0	-1	-2	-2	-16	-130	-26	-50	-32	-17
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Biovie Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-8	-8	-4	-4	-7	-2	-3	-5	-6
Operating Cash Flow	-5	-5	-4	-3	-8	-1	-5	-3	-4
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	4	15	-2	0	12	-	12,725,941	10	-
Change in Cash	0	10	-6	-3	4	-1	-5	7	-4

Biovie Inc Annual Cash Flow

All numbers in Millions USD

	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Net Income	-1	-2	-2	-16	-130	-26	-50	-32	-17
Operating Cash Flow	0	0	-2	-1	-10	-18	-40	-27	-19
Investing Cash Flow	-	-	-	-14	-14	-14	-14	14	-
Financing Cash Flow	0	0	2	1	14	33	55	17	12
Change in Cash	0	0	0	0	4	14	0	4	-6

Global Institutional Holdings in Biovie Inc

Funds	Holdings
Citadel Advisors Llc	0.24%
Tower Research Capital LLC	0.01%
Two Sigma Investments LLC	0.28%
Tradewinds Capital Management, LLC	0%
Prosperity Wealth Management Inc	1.9%

See all

Insights on Biovie Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 65.2% return, outperforming this stock by 165.1%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 29.6% return, outperforming this stock by 116.5%
NEGATIVE IMPACT
Price Dip
In the last 1 year, BIVI stock has moved down by -86.9%

About Biovie Inc

biovie inc. (otc pink: bivi) is developing novel drug therapies for life-threatening complications of chronic liver disease. our initial target is ascites, which can occur in patients with advanced cirrhosis due to hepatitis, nash (non-alcoholic steatohepatitis), or alcoholism. ascites affects about 100,000 americans and carries an estimated 40% mortality rate within two years of being diagnosed. the company’s new drug candidate biv201 is about to enter a phase 2 clinical trial in the us. it’s based on a drug (terlipressin) not yet available in the us, but approved in about 40 countries for treating related complications of liver cirrhosis. the fda has never approved a drug to treat ascites and there is a significant unmet medical need for our novel therapy, which has orphan drug status. biovie has attracted funding from strategic investors including aspire capital, cuong do, the global strategy lead for samsung, and hari kumar, founder of adheron therapeutics which he sold to roche fo

Organisation	Biovie Inc
Headquarters	680 W. Nye Lane, Carson City, NV, United States, 89703
Industry	Biotechnology
CEO	Mr. Cuong Viet Do M.B.A.
E-voting on shares	Click here to vote

Key Management of Biovie Inc

Name	Title
Dr. Joseph M. Palumbo M.D.	Executive VP of R&D and Chief Medical Officer
Mr. Clarence N. Ahlem	Senior Vice President of Operations
Dr. Penelope Markham Ph.D.	Senior Vice President of Liver Disease Program
Ms. Denise Smith	Senior Vice President of Manufacturing & Development
Dr. Christopher L. Reading Ph.D.	Senior Vice President of Alzheimer's Disease Program
Mr. David Morse	Senior VP & Chief Regulatory Officer
Mr. Cuong Viet Do M.B.A.	President, CEO & Director
Ms. Joanne Wendy Kim CPA	CFO, Treasurer & Corporate Secretary

FAQs

What is Biovie Inc share price today?

Biovie Inc share price today is $1.45 as on March 17, 2026 at 1:29 am IST at the close of the market. Biovie Inc share today touched a day high of $1.46 and a low of $1.38.

What is the 52 week high and 52 week low for Biovie Inc share?

Biovie Inc share touched a 52 week high of $13.2 on May 5, 2025 and a 52 week low of $1.06 on February 5, 2026. Biovie Inc stock price today i.e. March 17, 2026 at 1:29 am IST is closed at $1.45,which is 89.02% down from its 52 week high and 36.79% up from its 52 week low.

What is Biovie Inc's market capitalisation today?

Biovie Inc market capitalisation is $0.00T as on March 17, 2026 at 1:29 am IST.

How to invest in Biovie Inc Stock (BIVI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Biovie Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Biovie Inc Shares that will get you 1.0345 shares as per Biovie Inc share price of $1.45 per share as on March 17, 2026 at 1:29 am IST.

What is the minimum amount required to buy Biovie Inc Stock (BIVI) from India?

Indian investors can start investing in Biovie Inc (BIVI) shares with as little as ₹92.335 or $1 (as of March 17, 2026 at 2:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹923.35 in Biovie Inc stock (as per the Rupee-Dollar exchange rate as on March 17, 2026 at 2:41 am IST). Based on Biovie Inc share’s latest price of $1.45 as on March 17, 2026 at 1:29 am IST, you will get 6.8966 shares of Biovie Inc. Learn more about fractional shares .

What are the returns that Biovie Inc has given to Indian investors in the last 5 years?

Biovie Inc stock has given -99.93% share price returns and 27.61% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?